Bital Savir-Baruch MD, FACNM (@bitalsavirbmd) 's Twitter Profile
Bital Savir-Baruch MD, FACNM

@bitalsavirbmd

Professor of Radiology, Chief of Nuclear Medicine. University of Arizona, Tucson, AZ #nuclearmedicine #Precisionmedicine #theranostics @UAZmedimaging

ID: 765879624643510272

calendar_today17-08-2016 11:55:06

180 Tweet

353 Followers

230 Following

SNMMI (@snm_mi) 's Twitter Profile Photo

Novartis has received FDA approval to supply Pluvicto from its Millburn, NJ, plant, with plans to ramp up production in the coming weeks. SNMMI will share more information as it becomes available. ow.ly/Y7tv50NPpHJ #NuclearMedicine #RPTherapy #ProstateCancer

Novartis has received FDA approval to supply Pluvicto from its Millburn, NJ, plant, with plans to ramp up production in the coming weeks. SNMMI will share more information as it becomes available. ow.ly/Y7tv50NPpHJ #NuclearMedicine #RPTherapy #ProstateCancer
Bital Savir-Baruch MD, FACNM (@bitalsavirbmd) 's Twitter Profile Photo

Super excited to be promoted to a full Professor! I am privileged to be part of the UArizona Department of Medical Imaging I am so proud to be a part of this amazing Nuclear Medicine team! Thank you for all my mentors! More to come!

Super excited to be promoted to a full Professor! I am privileged to be part of the <a href="/UAZMedImaging/">UArizona Department of Medical Imaging</a>  I am so proud to be a part of this amazing Nuclear Medicine team! Thank you for all my mentors! More to come!
Bital Savir-Baruch MD, FACNM (@bitalsavirbmd) 's Twitter Profile Photo

We are hiring two Nuclear Medicine Technologists. If you are interested in a great atmosphere and a fast growing division, come and join us. Banner University Medical Center, Tucson. There is a signing bonus* UArizona Department of Medical Imaging * bannerhealth.wd5.myworkdayjobs.com/Careers/job/BU…

Michael Hofman (@drmhofman) 's Twitter Profile Photo

PSMA PET era highlighting the limitations of bone scanning. 167 patients: 57% of "positive" bone scans were false positive (FP). Those sticking with bone scan because of "stage migration" need to move on - FP harmful, never benefit patients. meetings.asco.org/abstracts-pres… @asco #asco23

PSMA PET era highlighting the limitations of bone scanning. 167 patients: 57% of "positive" bone scans were false positive (FP). Those sticking with bone scan because of "stage migration" need to move on - FP harmful, never benefit patients.
meetings.asco.org/abstracts-pres… @asco #asco23
JNM (@journalofnucmed) 's Twitter Profile Photo

Cardiac amyloidosis: ⁹⁹mTc-DPD scintigraphy may provide useful imaging biomarkers to assess response to treatment. ow.ly/BlOH50OKK5c #MolecularImaging #NuclearMedicine #HeartDisease Maria Papathanasiou Christoph Rischpler

Cardiac amyloidosis: ⁹⁹mTc-DPD scintigraphy may provide useful imaging biomarkers to assess response to treatment. ow.ly/BlOH50OKK5c

#MolecularImaging #NuclearMedicine #HeartDisease <a href="/papathanasiou_/">Maria Papathanasiou</a> <a href="/rischpler/">Christoph Rischpler</a>
SNMMI (@snm_mi) 's Twitter Profile Photo

Proud to announce that during the SNMMI House of Delegates Meeting, the winner of our chapter membership recruitment competition was unveiled! Congratulations to the Central Chapter for their efforts. #SNMMI2023 #SNMMI23

Proud to announce that during the SNMMI House of Delegates Meeting, the winner of our chapter membership recruitment competition was unveiled! Congratulations to the Central Chapter for their efforts. #SNMMI2023 #SNMMI23
Mary Beth Farrell (@nuclear_mbf) 's Twitter Profile Photo

Let's see what you know about cardiac amyloidosis imaging. #JNMTCE #JNMTPracticalPointer Which of these radiopharmaceuticals is not used for cardiac amyloidosis imaging?

SNMMI (@snm_mi) 's Twitter Profile Photo

The U.S. FDA has granted full approval to Leqembi, which has been shown to slow the progression of Alzheimer’s in patients with mild dementia; but CMS has not committed to reimbursement of the needed PET scans. ow.ly/JagA50P815z #NuclearMedicine #Alzheimer #FINDAct23

The U.S. FDA has granted full approval to Leqembi, which has been shown to slow the progression of Alzheimer’s in patients with mild dementia; but CMS has not committed to reimbursement of the needed PET scans. ow.ly/JagA50P815z
#NuclearMedicine #Alzheimer #FINDAct23
Sarah Fermawi, MD (@fermawimd) 's Twitter Profile Photo

📢 Exciting news! My abstract "Does Pre-Therapy PSA Influence 177Lu-PSMA-617 Treatment Outcomes?" has been selected for an Oral Presentation at the EANM'24 Congress in Hamburg, Germany! 🎉 #EANM24 #NuclearMedicine UArizona Department of Medical Imaging Bital Savir-Baruch MD, FACNM Tina Buehner, PhD